Athersys Inc (ATHXQ)

[goupupup]

It Seems our company have been BUSY behind the scenes .. With that being said the short position is now @18,980,000 up from 15,300,000 and they have 13 days to cover ... Also, Friday's trading volume 1,758,437 versus average 1,460,000 ... GOOD LUCK LONGS

Athersys to Participate in Two Upcoming Investor Conferences .... Company presentations is scheduled at the Locust Walk Stem Cell Conference, April 11, and at the Needham Healthcare Conference, April 13 ..

CLEVELANDAthersys, Inc. (Nasdaq: ATHX) announced today that William (B.J.) Lehmann, President and Chief Operating Officer, will present a corporate overview at the virtual Locust Walk Stem Cell Conference on Monday, April 11, 2022 at 2:00 p.m. ET. Mr. Lehmann will discuss the Company’s investigational clinical product platform, MultiStem® (invimestrocel) cell therapy, which is in late-stage clinical development in the areas of ischemic stroke, acute respiratory distress syndrome (ARDS) and trauma.

Additionally, Dan Camardo, Chief Executive Officer, will present a corporate overview at the 21st Annual Needham Virtual Healthcare Conference on Wednesday, April 13, 2022 at 10:15 a.m. ET. Mr. Camardo will discuss the Company’s clinical programs and its preparations for potential commercialization of MultiStem. The Company’s management team will also participate in one-on-one meetings with institutional investors during the Needham Healthcare Conference.

A live webcast of both presentations can be accessed by visiting ‘Events & Presentations’ in the Investors Section on the Company's website. An archived replay of the webcast will be available on the Company's website after the conference for a limited time.